lunes, 24 de julio de 2023

Drug Trials Snapshots: LEQVIO (inclisiran)

Drug Trials Snapshots: LEQVIO (inclisiran) https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-leqvio LEQVIO is a drug for the treatment of high low-density lipoprotein (LDL) cholesterol, which is sometimes referred to as “bad cholesterol”.

No hay comentarios:

Publicar un comentario